ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Wave Life Sciences Ltd

Wave Life Sciences Ltd (WVE)

5.94
0.47
(8.59%)
Closed September 19 4:00PM
5.94
-0.01
(-0.17%)
After Hours: 7:11PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
5.94
Bid
5.80
Ask
6.00
Volume
494,560
5.66 Day's Range 5.99
3.50 52 Week Range 7.67
Market Cap
Previous Close
5.47
Open
5.76
Last Trade
1
@
5.95
Last Trade Time
Financial Volume
$ 2,908,134
VWAP
5.8802
Average Volume (3m)
692,449
Shares Outstanding
124,737,862
Dividend Yield
-
PE Ratio
-12.90
Earnings Per Share (EPS)
-0.46
Revenue
115.18M
Net Profit
-57.51M

About Wave Life Sciences Ltd

WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic def... WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Singapore, Sgp
Founded
-
Wave Life Sciences Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker WVE. The last closing price for Wave Life Sciences was $5.47. Over the last year, Wave Life Sciences shares have traded in a share price range of $ 3.50 to $ 7.67.

Wave Life Sciences currently has 124,737,862 shares outstanding. The market capitalization of Wave Life Sciences is $682.32 million. Wave Life Sciences has a price to earnings ratio (PE ratio) of -12.90.

WVE Latest News

Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy

Designation highlights significant unmet needs in DMD; dystrophin data from potentially registrational FORWARD-53 trial of WVE-N531 are on track for 3Q 2024 In previous Part A trial, WVE-N531...

Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update

Successful clinical translation of Wave’s RNA medicines platform in HD patients with WVE-003 provides further validation of Wave’s proprietary platform with PN and stereochemistry; opt-in package...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.03-0.5025125628145.976.035.474788425.7960106CS
40.081.365187713315.866.155.045066695.67481234CS
121.6337.8190255224.316.8554.256924495.71372384CS
260.284.946996466435.666.8554.257322225.61680423CS
520.917.85714285715.047.673.57354795.41337968CS
1560.366.451612903235.587.671.165412224.54250667CS
260-19.74-76.869158878525.6839.991.166087937.03101847CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GSIWGarden Stage Ltd
$ 8.17
(259.91%)
70.64M
ZEOZeo Energy Corporation
$ 2.5995
(128.03%)
58.94M
TBIOTelesis Bio Inc
$ 2.9201
(114.71%)
45.91M
NCINeo Concept International Group Holdings Ltd
$ 0.84
(71.43%)
12.68M
VEROVenus Concept Inc
$ 0.8475
(68.66%)
19.72M
HAOHaoxi Health Technology Ltd
$ 0.83
(-72.33%)
8.28M
PGNYProgyny Inc
$ 16.465
(-32.63%)
19.16M
NUZENuZee Inc
$ 0.6998
(-32.06%)
14.06M
RGFReal Good Food Company Inc
$ 0.308
(-28.37%)
363.05k
ALGSAligos Therapeutics Inc
$ 10.18
(-28.11%)
875.5k
NVDANVIDIA Corporation
$ 117.87
(3.97%)
293.54M
SQQQProShares UltraPro Short QQQ
$ 7.76
(-7.62%)
222.56M
HOLOMicroCloud Hologram Inc
$ 0.2328
(15.08%)
120.19M
MAXNMaxeon Solar Technologies Ltd
$ 0.1034
(13.75%)
105.03M
TSLATesla Inc
$ 243.92
(7.36%)
102.7M

Your Recent History

Delayed Upgrade Clock